Humoral and cell-mediated immune responses to an early 2-dose measles vaccination regimen in the United States
HA Gans, J Ren, LL Yasukawa… - The Journal of …, 2004 - academic.oup.com
Background. Shifts in peak measles incidence to children< 12 months old and the
associated high mortality support the study of an early 2-dose measles vaccine regimen …
associated high mortality support the study of an early 2-dose measles vaccine regimen …
Measles transmission and vaccine effectiveness during a large outbreak on a densely populated island: implications for vaccination policy
M Marin, HQ Nguyen, JR Langidrik… - Clinical infectious …, 2006 - academic.oup.com
Abstract Background. The Republic of the Marshall Islands (RMI) is a South Pacific nation
freely associated with the United States. In 2003, the RMI experienced the largest measles …
freely associated with the United States. In 2003, the RMI experienced the largest measles …
Waning of measles maternal antibody in infants in measles elimination settings–a systematic literature review
FM Guerra, NS Crowcroft, L Friedman, SL Deeks… - Vaccine, 2018 - Elsevier
Introduction Most infants are born with immunity to measles through maternal antibodies
transferred in pregnancy, which decay over time. However, in measles elimination settings …
transferred in pregnancy, which decay over time. However, in measles elimination settings …
Measles humoral and cell-mediated immunity in children aged 5–10 years after primary measles immunization administered at 6 or 9 months of age
HA Gans, LL Yasukawa, P Sung… - The Journal of …, 2013 - academic.oup.com
Background. Given the high infant measles mortality rate, there is interest in whether a
measles immunization regimen beginning at< 12 months of age provides lasting immunity …
measles immunization regimen beginning at< 12 months of age provides lasting immunity …
Comparison of vaccination with measles-mumps-rubella vaccine at 9, 12, and 15 months of age
SC Redd, GE King, JL Heath, B Forghani… - The Journal of …, 2004 - academic.oup.com
To determine seroconversion rates with measles-mumps-rubella vaccine administered to
children at 9, 12, or 15 months of age, we undertook a prospective randomized trial. Among …
children at 9, 12, or 15 months of age, we undertook a prospective randomized trial. Among …
Measles: old vaccines, new vaccines
DE Griffin, CH Pan - Measles: Pathogenesis and Control, 2009 - Springer
Isolation of measles virus in tissue culture by Enders and colleagues in the 1960s led to the
development of the first measles vaccines. An inactivated vaccine provided only short-term …
development of the first measles vaccines. An inactivated vaccine provided only short-term …
[HTML][HTML] Lower transplacental antibody transport for measles, mumps, rubella and varicella zoster in very preterm infants
JP van den Berg, EAM Westerbeek, GP Smits… - PLoS …, 2014 - journals.plos.org
Background Maternal antibodies, transported over the placenta during pregnancy,
contribute to the protection of infants from infectious diseases during the first months of life …
contribute to the protection of infants from infectious diseases during the first months of life …
Outbreak of measles in the Republic of Korea, 2007: importance of nosocomial transmission
WS Choi, DH Sniadack, Y Jee, UY Go… - The Journal of …, 2011 - academic.oup.com
Abstract Background. From 2002 through 2006, Republic of Korea conducted extensive
measles elimination activities and declared elimination in 2006. An outbreak of measles …
measles elimination activities and declared elimination in 2006. An outbreak of measles …
Comparison of immunogenicity and reactogenicity of a measles, mumps and rubella (MMR) vaccine in German children vaccinated at 9–11, 12–14 or 15–17 months …
J Klinge, S Lugauer, K Korn, U Heininger, K Stehr - Vaccine, 2000 - Elsevier
Children aged 9–11, 12–14 or 15–17 months, respectively were vaccinated with a measles,
mumps and rubella (MMR) vaccine and serum antibody responses and reactogenicity were …
mumps and rubella (MMR) vaccine and serum antibody responses and reactogenicity were …
Immunogenicity of aerosol measles vaccine given as the primary measles immunization to nine-month-old Mexican children
RM Wong-Chew, R Islas-Romero… - Vaccine, 2006 - Elsevier
Aerosol measles vaccination has been found to be more immunogenic than subcutaneous
administration as a booster in school aged children, and immunogenic in 12-month-old …
administration as a booster in school aged children, and immunogenic in 12-month-old …